本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Galmed Pharmaceuticals

4.63
0.0000
成交量:- -
成交額:- -
市值:482.26萬
市盈率:-0.33
高:4.63
開:4.63
低:4.63
收:4.63
52周最高:13.20
52周最低:3.29
股本:104.16萬
流通股本:97.47萬
量比:4.33
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):-14.1059
每股收益(LYR):-19.1292
淨資產收益率:-68.21%
總資產收益率:-30.19%
市淨率:0.38
市盈率(LYR):-0.24

資料載入中...

2021/01/15

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/11/12

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/08/06

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/07/28

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/03/12

年度報告

Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/03/12

財報披露

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/11/06

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/31

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/26

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/05

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/13

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/07

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/09

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/04

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/13

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/12

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/26

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]